Boesken W H
Curr Probl Clin Biochem. 1979(9):235-48.
Different types of urinary protein excretion may be recognized by determination of the proteins molecular weight. Beside chromatography different electrophoretic procedures have been applied to urinary proteins to study the underlying renal disease. The various zone electrophoreses separate merely by surface charge, proteins however covered by sodium dodecyl sulfate (SDS) migrate according to their molecular radius. So by SDS-polyacrylamide electrophoresis (SDS-PAe) macromolecular proteinurias (Mr 60,000- greater than 300,000 daltons) due to glomerular damage may be distinguished from micromolecular forms (Mr 10,000-70,000 d) due to tubular dysfunction. By densitometric quantitation of the separated Ig and transferrin an index of the glomerular selectivity is obtained, i.e. the capacity of the glomerular system, to retain serum proteins of a Mr above 150,000 d. By this procedure proliferative and degenerative glomerulopathies may be distinguished from minimal change disease, focal glomerular sclerosis and early membranous nephropathy; serial determinations of this selectivity index in the latter two disease entities show a gradual deterioration of glomerular protein handling with time. A glomerular proteinuria of even "physiological" quantity has been proved as early sign of renal involvment in systemic diseases; it may be detected earlier as for example the retinopathy in juvenile diabetics. Micromolecular proteinurias also occur at least in two forms: the typical tubular proteinuria (MW 10,000-70,000 d) is associated with acute or chronic severe tubular dysfunction as in interstitial nephritis and acute kidney failure; rejection episodes of kidney transplants lead to transient tubular proteinurias, too. The second form of micromolecular proteinuria (Mr 40,000-70,000 d) has been found frequently in association with a glomerular in diabetic and hypertensive glomerulosclerosis. By measuring clearances of the microproteins, the proteinuria with this pattern could be established as form independant from glomerular and tubular proteinurias. The constancy of the two micromolecular proteinurias led to the hypothesis of at least two selective mechanism of tubular protein resorption. SDS-PAe additionally allows the differentiation of extrarenal proteinurias, as caused by overflow, paraproteins, postrenal Ig-secretion or bleeding etc. In comparing clinical and in part histological data of about 2,000 patients suffering from kidney diseases the analysis of urinary proteins by this method has been proved as valuable non-invasive tool for diagnosis and follow-up.
通过测定蛋白质分子量可识别不同类型的尿蛋白排泄。除了色谱法外,不同的电泳方法也已应用于尿蛋白,以研究潜在的肾脏疾病。各种区带电泳仅根据表面电荷分离蛋白质,然而,被十二烷基硫酸钠(SDS)覆盖的蛋白质则根据其分子半径迁移。因此,通过SDS-聚丙烯酰胺电泳(SDS-PAe),可将由于肾小球损伤导致的大分子蛋白尿(分子量60,000 - 大于300,000道尔顿)与由于肾小管功能障碍导致的小分子蛋白尿(分子量10,000 - 70,000道尔顿)区分开来。通过对分离出的免疫球蛋白(Ig)和转铁蛋白进行光密度定量,可获得肾小球选择性指数,即肾小球系统保留分子量高于150,000道尔顿血清蛋白的能力。通过该方法,增殖性和退行性肾小球病可与微小病变病、局灶性肾小球硬化和早期膜性肾病区分开来;对后两种疾病实体中该选择性指数的连续测定表明,随着时间推移,肾小球对蛋白质的处理能力逐渐恶化。即使是“生理性”量的肾小球蛋白尿也已被证明是系统性疾病肾脏受累的早期迹象;它可能比例如青少年糖尿病患者的视网膜病变更早被检测到。小分子蛋白尿至少也以两种形式出现:典型的肾小管蛋白尿(分子量10,0 — 70,000道尔顿)与急性或慢性严重肾小管功能障碍相关,如间质性肾炎和急性肾衰竭;肾移植排斥反应也会导致短暂的肾小管蛋白尿。小分子蛋白尿的第二种形式(分子量40,000 - 70,000道尔顿)在糖尿病和高血压肾小球硬化症中常与肾小球病变相关。通过测量微蛋白的清除率,可确定这种模式的蛋白尿是一种独立于肾小球和肾小管蛋白尿的形式。两种小分子蛋白尿的稳定性导致了关于肾小管蛋白重吸收至少存在两种选择性机制的假说。SDS-PAe还可区分肾外蛋白尿,如由溢出、副蛋白、肾后Ig分泌或出血等引起的蛋白尿。在比较约2000例肾病患者的临床及部分组织学数据时,通过该方法分析尿蛋白已被证明是一种用于诊断和随访的有价值的非侵入性工具。